T1	Participants 257 282	Barrett's esophagus (BE).
T2	Participants 597 670	consecutive patients with BE or those referred for diagnostic assessment.
T3	Participants 1031 1078	95 patients randomized, 82 completed the study.
T4	Participants 2037 2053	of patients with
